Agenda
May 9, 2024 09:00
New Research in VTE
Prof Beverley Hunt OBE
PROFESSOR BEVERLEY HUNT OBE
Founder of Thrombosis UK and Professor of Haemostasis & Thrombosis, Guy's & St Thomas's Hospital, London.
Professor Beverley Hunt OBE is a consultant in the departments of haematology & pathology. She is a national and international expert in thrombosis and acquired bleeding disorders.
She has sat on multiple national and international guideline writing groups, including NICE has extensive clinical experience of thrombotic and acquired bleeding disorders and runs a very active research group with over 500 peer-reviewed publications to her name.
Prof Hunt is past chair of the steering committee of World Thrombosis Day.
Dr Daniel Horner
Dr Dan Horner, Consultant in Emergency and Critical Care Medicine; Northern Care Alliance NHS Foundation Trust
Dan Horner is a consultant in emergency medicine/intensive care at a major trauma and neurosciences centre in the North West of England. He is the outgoing Professor of the Royal College of Emergency Medicine and has research interests in the prevention and treatment of venous thromboembolic disease, trauma coagulopathy and early sepsis management.
Dan is a topic expert for several NICE guidelines, including NG158 on VTE diagnosis and management, and the accompanying quality standards. Dan also chairs the thrombosis committee at his local hospital, which is an accredited national exemplar centre for VTE care. He occasionally blogs (stemlynsblog.org) and infrequently tweets (@exRCEMProf).
https://www.research.manchester.ac.uk/portal/daniel.horner.html
Dr Francine Heatley
Dr Francine Heatley is a Trial Manager in the Section of Vascular Surgery (Surgery and Cancer) within the Faculty of Medicine at Imperial College.
Francine is a Biology graduate from the University of Nottingham with 20 years experience of conducting clinical research in therapeutic areas such as vascular surgery, cardiovascular and oncology . She spent 3 years working for an academic research organisation in Canada and is familiar in both Health Canada and FDA clinical trial regulations.
At Imperial, she currently manages the NIHR funded GRACE study investigating the use of graduated compression stockings in high risk surgical patients. Previously, she has managed the NIHR DM-PAD study investigating the best diagnostic test for the detection of peripheral arterial disease in patients with diabetes, the JP Moulton funded DAVE (Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration) Trial and the NIHR EVRA (Early Venous Reflux Ablation) ulcer trial: A randomised clinical trial to compare early versus delayed endovenous treatment of superficial venous reflux in patients with chronic venous ulceration.
Francine completed her PhD in Leg Ulcer outcomes at Imperial College London in June 2021.
Sarah Whittley
Sarah Whittley is a Clinical Trial Manager within the Department of Surgery and Cancer at Imperial College London. As a Clinical Trial Manager, Sarah assists in all aspects of clinical trial conduct, from initial design through to successful delivery and dissemination of results. Sarah is also pursuing a PhD within the department.
Sarah is currently setting up the THRIVE trial, which aims to examine the most clinically and cost effective thromboprophylaxis regimen in patients undergoing superficial endovenous intervention.
Dr Xavier Griffin
Sarrah Peerbux
Sarrah Peerbux is based at Imperial College London and is the Trial Manager for the NIHR-HTA funded PETS study, a multi-centre cluster RCT examining the benefit of graduated compression stockings for the prevention of VTE in patients who undergo short-stay surgical procedures and who are assessed as low-risk of developing VTE. Sarrah has over 10 years experience managing a range of clinical trials and cohort observation projects across both academia and industry.
- The GRACE trial
- The THRIVE Trials
- Updates in learning from the PETS trial
- Updates on, ‘Thrombosis in Lower Limb Immobilisation’ study (TiLLI)
- The DIRECT Study
May 9, 2024 10:45
All Scotland at NTW
Dr Catherine Bagot
Dr Catherine Bagot is a Consultant Haematologist at Glasgow Royal Infirmary (GRI), specialising in Haemostasis and Thrombosis, and is the co-director of the West of Scotland Haemophilia and Thrombosis centre. She is the joint lead of the Haematology Obstetric service in North Glasgow and has been running the Haematology Obstetric clinic at the Princess Royal Maternity Unit at Glasgow Royal Infirmary for the last 10 years, alongside her consultant obstetric colleague, Dr Vicki Brace.
She is chair and secretary of the GRI and Greater Glasgow and Clyde Thrombosis Committees respectively. She is an elected committee member of the British Society of Haemostasis and Thrombosis.
Her clinical interests include inherited bleeding disorders, venous thrombosis treatment and prevention, obstetric haematology and immune thrombocytopaenia (ITP). Her main research interest is the application of thrombin generation to clinical thrombotic issues. She is currently leading a research project investigating the pathophysiology underlying the increased risk of venous thrombosis in obese pregnant women, funded by a British Heart Foundation Clinical Research Fellowship Award. She is also principal investigator for a number of international trials investigating new treatments for haemophilia and ITP
Dr Colum O'Hare
Dr Colum O’ Hare is a Consultant Interventional and Diagnostic Radiologist at the Royal Infirmary of Edinburgh and the Borders General Hospital, Melrose.
His interests include peripheral arterial disease, venous intervention, hepatobiliary intervention and trauma.
Dr Robert Noble
Dr Hanan Mustafa
Dr Peter Douglas
Peter is a consultant vascular and interventional radiologist based in the QEUH in Glasgow. He has a special interest in the imaging and treatment of systemic and portal venous disorders, particularly in MR venography.
- Splanchnic Vein Thrombosis
- Superficial Thrombophlebitis in Pregnancy - how we treat
- IVC filters, insertion, retrieval, approach and considerations on complications
- The use of MR in difficult VTE cases
- The management of thoracic outlet syndrome in patients with upper limb DVT
- The use of DOACs in cancer associated VTE
May 9, 2024 13:30
AstraZeneca Sponsored Symposium
Dr Ander Cohen
Dr Cohen graduated with honours in Medicine and honours in Surgery from the University of Melbourne, Australia, and became a fellow of the Royal Australasian College of Physicians in 1990. He was awarded an MSc in epidemiology from the London School of Hygiene and Tropical Medicine, University of London, in 1991 with a thesis on the metabolic syndrome in South Asian populations. In 1998, he was awarded an MD with a thesis on the epidemiology of venous thromboembolism and thromboprophylaxis. He is a Fellow of the European Society of Cardiology.
In addition to his clinical work, Dr Cohen is involved in designing, managing, and analysing clinical trials from Phase I to IV. He is the Chairman and a member of many international steering committees for multicentre trials, epidemiological and pharmacoeconomic studies, and was previously the Director of Clinical Research and an epidemiologist in thrombosis research at King’s College Hospital.
Dr Cohen has written and co-authored over 500 publications and is on the editorial board of several journals.
Dr Vinay Sehgal
Consultant Gastroenterologist & Interventional Endoscopist
Vinay Sehgal is a Consultant Gastroenterologist and Interventional Endoscopist at University College Hospital, London. He graduated from The University of Liverpool and completed his specialist training in Gastroenterology in North East London. During this time, he completed his PhD at University College London where he developed a novel tumour model of oesophageal cancer used in crucial mechanistic, imaging and pre-clinical studies.
He has a specialist interest in the early detection of pre-malignant lesions of the Upper GI tract with particular expertise in artificial intelligence-based classification systems to improve lesion recognition of Barrett’s-related neoplasia. He also has a specialist interest in advanced endoscopic therapy for acute upper gastrointestinal bleeding and is lead investigator on numerous device studies in this regard.
Symposium Title: DOAC reversal and the management of life-threatening bleeds
DOAC reversal and the management of life-threatening bleeds – ICH – Dr Alexander (Ander Cohen) - Vascular Medicine / Haematology Guy’s and St Thomas’ Hospitals, King’s College, London
Management of FXa Inhibitor Related Life-Threatening GI Bleeding - Building the Evidence – Dr Vinay Sehgal - Consultant Gastroenterologist and Interventional Endoscopist, University College Hospital, London
This is an AstraZeneca sponsored promotional symposium at which AstraZeneca products will be discussed. This meeting is intended for UK healthcare professionals only.
May 9, 2024 14:45
UKCPA Symposium: Anticoagulation in Women’s Health
Katherine Stirling
Katherine Stirling is a consultant pharmacist for anticoagulation and thrombosis at Leeds Teaching Hospitals. She has been in post since 2011. Since 2019 she has also been working for 1 day a week with Leeds CCG GP confed team on the NHSE AF project.
Her role covers all areas of thrombosis and anticoagulation including VTE prevention. She is a member of the trusts thrombosis steering group and regularly attends VTE MDT meetings. Her clinical role involves out-patient anticoagulant clinics for patients on oral and injectable anticoagulants. He is a supervisor for a PhD student looking at the barriers and enablers to the uptake of DOACs and has a research interest in the use of DOACs at extremes of weight.
Rosalind Byrne
Rosalind Byrne
Rosalind Byrne is lead pharmacist for Anticoagulation at King’s College Hospital NHS Foundation Trust in London. She has been in post since 2008. She runs an outpatient clinic initiating and reviewing patients on anticoagulation with the direct oral anticoagulants and warfarin. She was part of a team who conducted an anticoagulation in AF project in South London which has now been rolled out nationally by NHSE. She is also involved in the wider management of patients on anticoagulation in conjunction with local CCGs and colleagues at local acute trusts. She is currently undertaking an MSc in Pharmacy Practice specifically conducting a project to compare the efficacy of warfarin and DOACs in the treatment of LV thrombus.
Wendy Sunter
Wendy Sunter
Consultant Pharmacist Anticoagulation and Thrombosis
Calderdale and Huddersfield NHS Foundation Trust
Wendy is a Consultant Pharmacist Anticoagulation and Thrombosis at Calderdale and Huddersfield NHS Foundation Trust (CHFT). She manages a primary care based anticoagulant service which delivers a “one-stop shop” for anticoagulants (DOAC and warfarin initiation, monitoring INR’s, bridging and reversal.)
She is vice-chair of CHFT’s Thrombosis Committee and was part of the team that achieved VTE exemplar status for the trust in 2023.
She is currently involved in the AF WAY project: working with primary care colleagues across West Yorkshire to “Detect, Protect and Perfect” treatment for those with AF who could benefit from life-saving anticoagulation.
She is Chair for the North of England Anticoagulant Pharmacists’ group; member of UKCPA Haemostasis and Thrombosis Committee, VTE specialist network and the Royal Pharmaceutical Society Faculty.
Before taking on her anticoagulant role, she worked as Education and Training lead and pre-registration pharmacist manager.
She is active in anticoagulant research and enjoys collaboration with Bradford and Huddersfield Universities: teaching and supporting undergraduate and postgraduate pharmacist research projects and publishing anticoagulant related papers.
Zoe Van-Zuylen
This webinar will cover the use of anticoagulation in women’s specific health. Suitable for HCPs involved in caring for women or responsible for making anticoagulation recommendations, and to improve specialist understanding of the managment of anticoagulation treatment in women's health.
The following topics will be covered:
- The management of heavy menstrual bleeding in patients taking anticoagulation.
- How to advise women requesting contraception or HRT who have a history of VTE.
May 7, 2024 09:00
Challenges in diagnosis of VTE
Prof Beverley Hunt OBE
PROFESSOR BEVERLEY HUNT OBE
Founder of Thrombosis UK and Professor of Haemostasis & Thrombosis, Guy's & St Thomas's Hospital, London.
Professor Beverley Hunt OBE is a consultant in the departments of haematology & pathology. She is a national and international expert in thrombosis and acquired bleeding disorders.
She has sat on multiple national and international guideline writing groups, including NICE has extensive clinical experience of thrombotic and acquired bleeding disorders and runs a very active research group with over 500 peer-reviewed publications to her name.
Prof Hunt is past chair of the steering committee of World Thrombosis Day.
Dr Matthew Fay
GP and Trustee of Thrombosis UK
Dr Matthew Fay is a General Practitioner who joined Westcliffe Medical Practice in 1999. This has developed into the Affinity Care, a 27 partner “superpractice” based in Bradford managing 8 GP contracts and providing care for over 64,000 population.
In 2001 Matthew established a GPwSI cardiology service in Bradford which has expanded to provide direct access investigations and e-consultations.
He was a member of the NICE AF Guideline Development Group and was a standing committee member of the NICE Quality Standard Advisory Committee. He is currently a clinical advisor to the AF Association, STARS (the Syncope Trust), Arrhythmia Alliance, on the Expert Advisory Panel for the Stroke Association and on the faculty for Heart Valve Voice. He is a Trustee of the AF Association and Thrombosis UK. He has been involved in service redesign of cardiovascular services with a focus on AF, dysrhythmia and moving services out of hospital for many years. He was the clinical lead of the redesign of the Bradford VTE services to make it completely community and DOAC based.
He has previously worked in Bradford’s PCTs and CCG. As a father of four he insists that he is first and foremost a family doctor.
Prof Catherine Nelson-Piercy
Catherine Nelson-Piercy is a Professor of obstetric medicine and consultant obstetric physician.
She specialises in the care of women with medical problems in pregnancy. She offers pre-pregnancy counselling for women with pre-existing medical problems and those with problems in previous pregnancies. Catherine runs special joint clinics for women with renal disease, cardiac and rheumatic disorders, hypertension and epilepsy in pregnancy.
She is the immediate past president of the International Society of Obstetric Medicine, editor in chief of the journal 'Obstetric Medicine: the medicine of pregnancy' and has over 200 publications. She has been one of the central assessors for the confidential enquiry into maternal deaths in the UK since 2005 and is a trustee for the charity APEC- Action on Pre-eclampsia.
- Presentation in primary care
- Inadequacies of current diagnosis of VTE on non pregnant and pregnant
May 7, 2024 10:45
A new thrombotic syndrome: Spontaneous VITT
Prof Beverley Hunt OBE
PROFESSOR BEVERLEY HUNT OBE
Founder of Thrombosis UK and Professor of Haemostasis & Thrombosis, Guy's & St Thomas's Hospital, London.
Professor Beverley Hunt OBE is a consultant in the departments of haematology & pathology. She is a national and international expert in thrombosis and acquired bleeding disorders.
She has sat on multiple national and international guideline writing groups, including NICE has extensive clinical experience of thrombotic and acquired bleeding disorders and runs a very active research group with over 500 peer-reviewed publications to her name.
Prof Hunt is past chair of the steering committee of World Thrombosis Day.
Dr Will Lester
Dr Will Lester is a Haematology Consultant at University Hospitals Birmingham, Queen Elizabeth and Birmingham Women’s Hospital and an Honorary Senior Clinical Lecturer in the Institute of Cardiovascular Sciences, University of Birmingham and has been a lecturer at the National Centre for Anticoagulant Training.
His interests include thrombosis and haemostasis, obstetric and general haematology. He has received two thrombus innovation awards for work on thrombosis prevention and is a member of the Haemostasis and Thrombosis task force for the British Society of Haematology guidelines committee.
Dr Sue Pavord
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Dr Sue Pavord is a consultant hematologist at Oxford University Hospitals NHS Foundation Trust, Oxford, UK. She is also an associate senior lecturer in medicine at St Edmund Hall, University of Oxford, and a fellow of the Royal College of Pathologists and Royal College of Physicians. Her special areas of interest are immunohaematology, hemostasis, thrombosis and obstetric hematology.
Dr Pavord has been a key player in the identification of Vaccine-induced immune thrombosis and thrombocytopenia (VITT) as a new syndrome occurring after COVID-19 vaccination. She is chair of the Expert Haematology Panel focused on VITT, which has guided the UK’s prevention and management of this condition, through daily meetings held over 4 months during the surge of patients, analysis of the cases, communications with the UK regulatory authorities and development of guidelines with the National Institute for Health and Care Excellence. These actions have helped reduce morbidity and mortality of this devastating condition.
Prof Marie Scully
Professor Marie Scully is a consultant haematologist at UCLH and Professor of haemostasis and thrombosis at UCL. My particular interests include platelet mediated disorders, specifically, ITP, TTP and aHUS and acquired bleeding and thrombotic conditions. Primary publications include TTP, in particular treatment and clinical subtypes, in conjunction with an understanding of the pathogenesis of the underlying disease. I am clinical lead for the national TTP service, UK TTP forum and patron for the TTP Network. I supervise postgraduate doctorates and am involved in undergraduate and postgraduate teaching and regularly reviews for haematology and related medical journals.
- How to recognise
- How to diagnose
- How to treat
May 7, 2024 12:00
Should.. and can ..we improve the quality of communication during consultations?
Prof Paul Bennett
Paul Bennett is a clinical and academic psychologist, who has worked in both NHS and universities in Bristol, Cardiff and Swansea. He has previously published research on the psychological impact of VTE, and is presently an emeritus professor of psychology at the University of Swansea and a clinical psychologist providing support for VITT patients through the auspices of Thrombosis UK.
May 7, 2024 13:00
Innovative care models for anticoagulation and VTE care
Prof Roopen Arya
Prof Roopen Arya is Professor of Thrombosis and Haemostasis and Clinical Director for Haematological Medicine at King's College Hospital. He is also Director of King's Thrombosis Centre and Director of the National VTE Exemplar Centres Network in England.
Roopen trained in Medicine at Oxford and completed his PhD in Molecular Medicine and Haematology training at King's. He was MRC Clinical Training Fellow at King's and Clinical Lecturer in Haematology before his appointment as Consultant Haematologist in 1999. His research interests focus on thrombosis, thrombophilia and anticoagulation. Advancing patient care around venous thromboembolism (VTE) prevention and treatment has been a long term theme in his group. The interface between thrombosis and women's health is also a major interest.
Rosalind Byrne
Rosalind Byrne
Rosalind Byrne is lead pharmacist for Anticoagulation at King’s College Hospital NHS Foundation Trust in London. She has been in post since 2008. She runs an outpatient clinic initiating and reviewing patients on anticoagulation with the direct oral anticoagulants and warfarin. She was part of a team who conducted an anticoagulation in AF project in South London which has now been rolled out nationally by NHSE. She is also involved in the wider management of patients on anticoagulation in conjunction with local CCGs and colleagues at local acute trusts. She is currently undertaking an MSc in Pharmacy Practice specifically conducting a project to compare the efficacy of warfarin and DOACs in the treatment of LV thrombus.
Dr Matthew Fay
GP and Trustee of Thrombosis UK
Dr Matthew Fay is a General Practitioner who joined Westcliffe Medical Practice in 1999. This has developed into the Affinity Care, a 27 partner “superpractice” based in Bradford managing 8 GP contracts and providing care for over 64,000 population.
In 2001 Matthew established a GPwSI cardiology service in Bradford which has expanded to provide direct access investigations and e-consultations.
He was a member of the NICE AF Guideline Development Group and was a standing committee member of the NICE Quality Standard Advisory Committee. He is currently a clinical advisor to the AF Association, STARS (the Syncope Trust), Arrhythmia Alliance, on the Expert Advisory Panel for the Stroke Association and on the faculty for Heart Valve Voice. He is a Trustee of the AF Association and Thrombosis UK. He has been involved in service redesign of cardiovascular services with a focus on AF, dysrhythmia and moving services out of hospital for many years. He was the clinical lead of the redesign of the Bradford VTE services to make it completely community and DOAC based.
He has previously worked in Bradford’s PCTs and CCG. As a father of four he insists that he is first and foremost a family doctor.
Dr Karen Breen
Dr Karen Breen is an experienced and renowned consultant haematologist at Guy’s and St Thomas’s hospital, London. Her specialties include thrombosis, obstetric haematology, and clotting, bleeding, and platelet disorders.
Dr Breen completed her basic medical training whilst in Ireland, achieving her MB BCh in 2000. She later received her membership with the Royal College of Physicians of Ireland before eventually receiving her fellowship with the Royal College of Pathology. Dr Breen received her postgraduate haematology speciality training mostly in Ireland. She later relocated to London to complete research on antiphospholipid syndrome which led to her receiving an MD in 2015.
Dr Breen has maintained a strong interest in her research. She continues to conduct research on antiphospholipid syndrome and thrombosis. Presently, she is involved in several current clinical trials and translational research. Dr Breen has had her work published in various peer-reviewed journals. On a regular basis, Dr Breen lectures both nationally and internationally.
- Anticoagulation stewardship
- DVT management in primary care
- PERT
May 7, 2024 14:15
Viatris Sponsored Symposium: When do you consider an alternative to heparin?
Dr Will Lester
Dr Will Lester is a Haematology Consultant at University Hospitals Birmingham, Queen Elizabeth and Birmingham Women’s Hospital and an Honorary Senior Clinical Lecturer in the Institute of Cardiovascular Sciences, University of Birmingham and has been a lecturer at the National Centre for Anticoagulant Training.
His interests include thrombosis and haemostasis, obstetric and general haematology. He has received two thrombus innovation awards for work on thrombosis prevention and is a member of the Haemostasis and Thrombosis task force for the British Society of Haematology guidelines committee.
May 7, 2024 15:00
Viatris Sponsored Round Table Meeting: When do you consider an alternative to heparin?
Dr Will Lester
Dr Will Lester is a Haematology Consultant at University Hospitals Birmingham, Queen Elizabeth and Birmingham Women’s Hospital and an Honorary Senior Clinical Lecturer in the Institute of Cardiovascular Sciences, University of Birmingham and has been a lecturer at the National Centre for Anticoagulant Training.
His interests include thrombosis and haemostasis, obstetric and general haematology. He has received two thrombus innovation awards for work on thrombosis prevention and is a member of the Haemostasis and Thrombosis task force for the British Society of Haematology guidelines committee.
Please join the discussion through the event's roundtable feature.
May 7, 2024 15:45
Selected Poster Presentations
Prof Simon Noble
Marie Curie Professor of Supportive & Palliative Medicine in Cardiff University and Honorary Consultant Royal Gwent Hospital Newport
Simon Noble is the Director of the Division of Population MEdeicdine at Cardiff University Medical School. His main research interests are in the management of venous thromboembolism in advanced cancer, the anticancer effects of heparins and the quality of life associated with VTE. He set up the South East Wales Cancer Associated Thrombosis Service which sees 500 new cases per year. He is currently chief investigator on the RfPB funded HIDDEN2 study and the HORIZON EU funded SERENITY study. He lead the international PELICAN study which explored the impact of cancer associated thrombosis (CAT) on patients in different countries and healthcare settings. He has sat on several clinical guideline groups including NICE CG89, ASH, BSH and several ISTH guidance documents. He is Medical Director of Thrombosis UK and medical advisor to Anticoagulation UK. He has published over one hundred original papers, twenty seven chapters and six books. His interests include hill walking, travel and hip-hop.
Dr Ulfat Sardar
I am Ulfat Sardar, a medical professional hailing from Pakistan. I completed my MBBS from Pakistan, Following my graduation, I pursued my internship in Pakistan, during which my dedication to patient care and work ethics were recognized with the Best House Officer Award
Subsequently, I successfully passed the MRCOG 1 exam and embarked on further studies. After clearing the PLAB exams and obtaining registration with the General Medical Council (GMC), I began my tenure as an F2 doctor at the Ashford and St. Peter's Hospital NHS Foundation Trust.Presently, I am serving as a Senior House Officer (SHO) in the Trauma and Orthopedic Department, where I continue to engage in patient care, clinical audits and professional development.)
Dr Daniel Dinarvand
Dr Daniel Dinarvand is a dedicated foundation doctor currently working at St. Peter's Hospital in Chertsey. He completed his undergraduate studies at the University of Plymouth and later obtained his postgraduate medical degree from the University of Buckingham with first-class honours. Daniel’s passion for education is evident through his active involvement in teaching medical students and fellow doctors. He is committed to sharing his knowledge and expertise to nurture the next generation of healthcare professionals.
Beyond his role in education, Dr Dinarvand is a fervent advocate for quality improvement in healthcare. He actively engages in various projects aimed at enhancing patient care and experiences. Through his leadership and participation in quality improvement initiatives, he demonstrates his unwavering dedication to advancing healthcare standards and outcomes.
Dr Andre Colindres Castillo
Andre is a Foundation Year 1 Doctor at Ashford and St Peter's Hospitals NHS Foundation Trust. Hailing from Honduras, he commenced his medical journey at Universidad Nacional Autonoma de Honduras. He later received a scholarship to pursue his studies in Taiwan, where he earned his primary medical qualification in 2022 from I-Shou University. Recognized for his exceptional performance, E-DA Hospital awarded him the "Best Clerk Award" for his outstanding two-year clinical clerkship.
Since 2023, Andre has made the United Kingdom his new home, demonstrating a strong commitment to furthering his training and contributing to the advancement of healthcare.
Dr Jack Pryce Lloyd
Gurpreet Bahra
Gurpreet Bahra is the Lead Anticoagulation and Thrombosis Pharmacist at Oxford University Hospitals NHS Foundation Trust.
Dr Yendrila Chatterjee
I'm Dr. Yendrila Chatterjee, presently employed as an SHO at Ashford and St. Peter’s NHS. I have graduated from India in 2022, and since then I've been actively engaged in patient care, clinical audits, and research.
My current focus is on advancing my medical career through postgraduate studies in Internal Medicine, and I'm actively pursuing that goal. I am passionate about representing this profession and guiding my fellow colleague. Thus, I am a proud BMA representative for my trust.
Dr Mary Liya Brigit
I'm Mary Liya Brigit, an MBBS graduate from India, currently working as an SHO in Trauma and Orthopedics at Ashford and St. Peter's Hospital.
I'm keen on becoming a proficient GP, focusing on honing my clinical skills, improving patient care, and actively participating in audits and research. With experience in both medical and non-medical teaching, I aim to contribute effectively to the healthcare profession.
- Adherence to guidelines when requesting an ultrasound Doppler for suspected DVT cases.
- Striving for Zero Adverse Outcomes: Audit and Implementation of VTE Prophylaxis Measures at St. Peter’s Hospital..
- Prospective VTE prophylaxis assessment and re- assessment audit in a university teaching hospital.
- The management of cancer-associated thrombosis.
May 8, 2024 08:30
Alexion Sponsored Symposium
Joanna Large
Joanna qualified as a nurse in 2006 and was lucky to immediately find her passion in haematology. She worked in transplant before becoming a clinical nurse specialist 14 years ago. She has an in-depth knowledge of PNH and bone marrow failures, runs independent nurse led clinics and an independently SACT prescriber. She has years of experience with this patient group, has run or been guest speaker at numerous patient support groups and has shared her expertise from the Alps to the Iraq! She has just completed a PG Cert in genomics and has a special interest in supporting the specialist nurse population to improve their understanding and feel confident to take a central role in the genomic era. Joanna is an RCN accredited advanced level nurse practitioner.
Joanna is happy to be contacted by HCP colleagues who may have questions about this area of health: joanna.large@nhs.net
May 8, 2024 09:30
DOACs in extremes of body weight
Prof Raza Alikhan
Dr Raza Alikhan
Consultant Haematologist, Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff
Dr Raza Alikhan is a consultant haematologist at the Haemophilia and Thrombosis Centre, University Hospital of Wales and member of the British Society for Haematology (BSH) Thrombosis and Haemostasis Task Force and Guideline Committee and Chair of the BSH Cancer Associated Thrombosis Guideline Writing Group. He is a Fellow of the Royal College of Pathologists and a Member of the Royal College of Physicians having received his medical degree from the University of London and completed postgraduate studies in London and Oxford. He defended his doctoral thesis on venous thromboembolism and prophylaxis in medical patients and was the UK National Lead Investigator for the rivaroxaban medical thromboprophylaxis study (MARINER). He is he UK Chief Investigator for both the apixaban treatment of cancer associated thrombosis study (CARAVAGGIO) and the apixaban length of stay pulmonary embolism study (ALPHA-PE).
Dr Alikhan has been involved in phase II–IV anticoagulant clinical trials since the late 90s. His current research interests include the identification of risk factors and outcomes associated with anticoagulation related bleeding. He is the UK Chief Investigator for the andexanet alfa DOAC and LMWH antidote study (ANNEXA-4) and is a member of the steering committee for the oral anticoagulant agent associated bleeding events reporting system (ORANGE) and the secure anonymised information linkage bleeding risk evaluation (SABRE) study. He has authored more than 100 conference abstracts, peer-reviewed papers and book chapters on thrombosis and haemostasis.
Tristan Groves
Tristan Groves is the lead anticoagulation and thrombosis pharmacist for Cardiff and Vale University Health Board. He is based at the Heath hospital in Cardiff and works as part of multidisciplinary teams for the treatment of patients with non- cancer and cancer associated venous thromboembolism, as well as providing expert support and education for both primary and secondary care physicians and allied healthcare professionals.
Over the past decade he has established and developed anticoagulation and thrombosis policies, pathways and guidelines for Health Boards across Wales. He is a member of the award-winning South Wales cancer associated thrombosis team and has helped establish a regional laboratory DOAC measuring service which supports the safe introduction of DOACS in the cancer thrombosis population.
His research interest includes areas; effect of extremes of body weight and renal function for patients treated for AF /VTE with DOACs and the potential for drug interactions with systemic anticancer therapies and anticoagulation.
He is also a member of the steering committee for the award winning all wales “Stop a Stroke / Atal Stroc” group set up to reduce AF related strokes across Wales, and his role also includes work as the pharmacist representative for the Welsh Cardiac Network.
May 8, 2024 10:45
VTE-SN Practicalities of DOACs with case studies: considerations when selecting a DOAC
Becs Walsh
Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust
Becs graduated from Bradford University with a Masters degree in Pharmacy in 2002 and undertook pre-registration pharmacy training in Sheffield, qualifying in 2003. She completed a post-graduate diploma in Clinical Pharmacy in 2005 completing rotations through various medical and surgical specialties. She worked in oncology and palliative care before becoming the first pharmacist to be employed in the role of thrombosis prevention & anticoagulation at Sheffield in 2009. Becs is an active member of the Yorkshire & Humber Anticoagulation Pharmacists group and professional secretary of the local thrombosis committee.
Alexandra Butler
Alexandra trained as a nurse in Leicester and qualified in 1993 and has since worked in ENT, Renal, Diabetes, Surgical Day Case before moving into the Haemostasis and Thrombosis specialities. She is currently the VTE Prevention Clinical Nurse Specialist at George Eliot Hospital NHS Trust in Nuneaton. She has implemented the VTE Prevention CNS role at Kettering General Hospital and Sheffield Teaching Hospitals prior to working at the George Eliot. She has also been the Haemophilia and Haematology Obstetric CNS while at Kettering and the VTE Ambulatory Clinic Nursing Lead while at Sheffield. Alexandra is the digital secretary for the VTE Specialist Network and has a special interest in education.
May 8, 2024 11:45
VTE-SN ROUND TABLE discussion on considerations when selecting a DOAC
Becs Walsh
Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust
Becs graduated from Bradford University with a Masters degree in Pharmacy in 2002 and undertook pre-registration pharmacy training in Sheffield, qualifying in 2003. She completed a post-graduate diploma in Clinical Pharmacy in 2005 completing rotations through various medical and surgical specialties. She worked in oncology and palliative care before becoming the first pharmacist to be employed in the role of thrombosis prevention & anticoagulation at Sheffield in 2009. Becs is an active member of the Yorkshire & Humber Anticoagulation Pharmacists group and professional secretary of the local thrombosis committee.
Alexandra Butler
Alexandra trained as a nurse in Leicester and qualified in 1993 and has since worked in ENT, Renal, Diabetes, Surgical Day Case before moving into the Haemostasis and Thrombosis specialities. She is currently the VTE Prevention Clinical Nurse Specialist at George Eliot Hospital NHS Trust in Nuneaton. She has implemented the VTE Prevention CNS role at Kettering General Hospital and Sheffield Teaching Hospitals prior to working at the George Eliot. She has also been the Haemophilia and Haematology Obstetric CNS while at Kettering and the VTE Ambulatory Clinic Nursing Lead while at Sheffield. Alexandra is the digital secretary for the VTE Specialist Network and has a special interest in education.
Please join the discussion through the event's roundtable feature.
May 8, 2024 12:00
Bayer Sponsored Symposium: VTE Extension Unravelled: Strategies for Long-Term Care
Dr Karen Breen
Dr Karen Breen is an experienced and renowned consultant haematologist at Guy’s and St Thomas’s hospital, London. Her specialties include thrombosis, obstetric haematology, and clotting, bleeding, and platelet disorders.
Dr Breen completed her basic medical training whilst in Ireland, achieving her MB BCh in 2000. She later received her membership with the Royal College of Physicians of Ireland before eventually receiving her fellowship with the Royal College of Pathology. Dr Breen received her postgraduate haematology speciality training mostly in Ireland. She later relocated to London to complete research on antiphospholipid syndrome which led to her receiving an MD in 2015.
Dr Breen has maintained a strong interest in her research. She continues to conduct research on antiphospholipid syndrome and thrombosis. Presently, she is involved in several current clinical trials and translational research. Dr Breen has had her work published in various peer-reviewed journals. On a regular basis, Dr Breen lectures both nationally and internationally.
Emma Gee
Emma graduated from Brighton University with an Adult Nursing Degree in 2001 and undertook a cross speciality rotation at Addenbrookes Hospital. After working in Perth, Australia as a surgical nurse for a year she worked in High Dependency Care for several years in Watford General and King's College Hospitals. In 2007 she joined Kings' Thrombosis Team as a Coagulation Clinical Nurse Specialist rotating through DVT, anticoagulation and VTE prevention roles.
Emma became the Nurse Consultant in Thrombosis and Coagulation with responsibility for the nursing thrombosis teams across King’s College Hospital sites in 2014 and became the lead for the VTE National Nursing and Midwifery Network at the same time. Emma completed an MSc in Advanced Practice and Leadership at King’s College London in 2018.
Dr Karen Breen and Emma Gee provide their expert opinion on strategies for long-term care in patients who had an initial VTE and may be at risk of recurrence, and give an overview of current VTE national and international clinical guidelines in this field.This promotional symposium has been organised and fully funded by Bayer PLC and is intended for UK heath care professionals only.
Prescribing information and Adverse event reporting will be available at the meeting.
View Prescribing Information and Adverse Event Reporting for Xarelto® (rivaroxaban)
Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc. Tel: 01182 063500 Fax: 01182 063703 Email: pvuk@bayer.com. Further information is available on the "contact" tab at www.bayer.co.uk.
RP-XAR-GB-5380 May 2024
May 8, 2024 13:15
All Wales at NTW
Andrea Croft
Originally trained as an SEN in the Royal Air Force, following a four year break abroad Andrea returned to the UK and in 1992 undertook Project 2000. After inheriting the management of the hospital Warfarin clinic in Bridgend General Hospital in 1995 she developed an interest in Anticoagulation. Since 2002 Andrea has pioneered and championed the need to manage all hospitalised patients appropriately keeping them safe from the associated risks of developing a Hospital Acquired Thrombosis (HAT). Since 2009 Andrea has held the role of HAT Project Lead in Abertawe Bro Morgannwg University Health Board. Andrea is Wales her passion and enthusiasm for Anticoagulation have taken her as far afield as Australia. In 2015 3 hospitals in Andrea's Health Board were recognised as Thrombosis Exemplar Centres.
Sue Wooller
Sue Wooller is Lead Pharmacist for Anticoagulation & Clinical Services at the Royal Glamorgan hospital. Her pharmacy career spans over 30 years, predominantly in hospitals in and around South Wales. Key achievements include developing and delivering a Pharmacy led anticoagulation service within Rhondda Cynon Taf which was innovative and integrated across primary and secondary care. Sue also led a multi-professional team to successfully reconfigure secondary care anticoagulation services from Consultant Haematologist to Pharmacy led. As pharmacists with a special interest in anticoagulation, Sue and the team subsequently managed the introduction of direct acting oral anticoagulants (DOACs) safely and effectively into their local anticoagulation pathways. Current services provided by the team include a DOAC initiation and counselling service alongside the traditional INR monitoring clinics for complex patients. Research interests include the use of patient self-testing for INR monitoring.
Tehmina Riaz
I have been working as a Senior Speciality Doctor in the Department of Obstetrics and Gynaecology at Princess of Wales Hospital since 2008.
Have been the lead developer of the Health Boards ‘VTE in pregnancy guidelines’ since 2010. I perform and supervise regular audits, deliver tutorials at new staff induction, developed local gynaecology VTE prevention guidelines and maintain close contacts with the medical and nursing team on a day to day basis. Have maintained a data base of all pregnancy related VTEs in the department since 2010.
I represent the CTMUHB Obstetrics & Gynaecology team on the local Thrombo-prophylaxis Committee and Champion the need for VTE surveillance for all women.
Christine Welburn
Christine is the Thromboprophylaxis Clinical Nurse Specialist at Ysbyty Glan Clwyd (YGC) Betsi Cadwaladr University Health Board North wales and has worked in this field since 2017. As part of her role she is involved with the identification and carrying out root cause analysis on all cases of hospital acquired thrombosis (HAT), education, audits, organising and presenting at symposium and presenting at thrombosis events. From presenting local data, case studies and giving real time feedback to clinicians on her thromboprophylaxis walk around and clinical governance meetings she has increased compliance in thromboprophylaxis practice and decreased the number of potential preventable HATs in YGC and across North Wales. Her work has been nationally recognised receiving multiple awards and gaining National Exemplar Site status for her health board. In 2023 Christine joined the Welsh Risk Pool Safety and Learning team to lead on the national VTE Wales programme. The VTE Wales programme aims to nationally standardise VTE practice across Wales in which Christine co-authored the national VTE strategy for Wales.
Dr Rhys Morris
Rhys Morris is the Director of Medical Physics and Clinical Engineering and the Director of CEDAR at the Cardiff & Vale University Health Board. He is also the Editor-in-Chief of the Journal of Medical Engineering and Technology, a Consultant Clinical Scientist, Chartered Engineer and Chartered Physicist.
He is an expect in mechanical prophylaxis for DVT and has published several papers on the use and effects of intermittent pneumatic compression in the prevention DVT. He has extensive experience in vascular ultrasound, including the diagnosis of DVT, and the Cardiff & Vale Vascular Ultrasound service is within his department. He has worked with medical device companies over many years to develop, test and validate vascular therapy and diagnostic devices, including various DVT prevention systems, and wound care devices for chronic venous insufficiency.
Leeanne Lewis
Leeanne Lewis (Assistant Director for Quality and Patient Safety)
Leeanne has worked for Aneurin Bevan University Health Board for twenty years. She is a graduate of Cardiff University and is a proud Pharmacist. She holds a Master’s degree in Clinical Pharmacy and has worked her entire career in Wales undertaking pharmacy roles in various specialities, within acute services. Leeanne has undertaken various senior leadership and management positions within the Pharmacy Department, including Divisional Lead Pharmacist for Scheduled Care, Principal Pharmacist for Clinical Services. She transitioned to Pharmacy Manager when the Grange University Hospital opened and established a new pharmacy team. She has an active interest in venous thrombosis and is a Thrombosis UK Ambassador.
In 2022, she took up the post as Assistant Director for Quality and Patient Safety and is working closely with Clinical Executives throughout the Health Board. She has continued leading on Thromboprophylaxis as an active member of the Health Board’s Thrombosis Committee and Vice Chair of the All-Wales HAT Steering Group.
- All Wales HAT Steering Group current position
- VTE Guidelines and their implementation in Obstetrics & Gynaecology – a local success story
- Standards for Scanning and Reporting of DVT & PE
- Enhancing Patient & Carer Experience
- APPLE Approach to VTE Prevention in the hospital setting
May 8, 2024 13:15
Bayer Sponsored Round Table Meeting: Long-Term VTE Extension: Navigating Treatment Continuity
Dr Karen Breen
Dr Karen Breen is an experienced and renowned consultant haematologist at Guy’s and St Thomas’s hospital, London. Her specialties include thrombosis, obstetric haematology, and clotting, bleeding, and platelet disorders.
Dr Breen completed her basic medical training whilst in Ireland, achieving her MB BCh in 2000. She later received her membership with the Royal College of Physicians of Ireland before eventually receiving her fellowship with the Royal College of Pathology. Dr Breen received her postgraduate haematology speciality training mostly in Ireland. She later relocated to London to complete research on antiphospholipid syndrome which led to her receiving an MD in 2015.
Dr Breen has maintained a strong interest in her research. She continues to conduct research on antiphospholipid syndrome and thrombosis. Presently, she is involved in several current clinical trials and translational research. Dr Breen has had her work published in various peer-reviewed journals. On a regular basis, Dr Breen lectures both nationally and internationally.
Emma Gee
Emma graduated from Brighton University with an Adult Nursing Degree in 2001 and undertook a cross speciality rotation at Addenbrookes Hospital. After working in Perth, Australia as a surgical nurse for a year she worked in High Dependency Care for several years in Watford General and King's College Hospitals. In 2007 she joined Kings' Thrombosis Team as a Coagulation Clinical Nurse Specialist rotating through DVT, anticoagulation and VTE prevention roles.
Emma became the Nurse Consultant in Thrombosis and Coagulation with responsibility for the nursing thrombosis teams across King’s College Hospital sites in 2014 and became the lead for the VTE National Nursing and Midwifery Network at the same time. Emma completed an MSc in Advanced Practice and Leadership at King’s College London in 2018.
Please join the discussion through the event's roundtable feature.
In this round table discussion meeting, Dr Karen Breen and Emma Gee provide their expert opinion on strategies for treatment continuity and long term management of patients at risk of VTE recurrence in line current VTE national and international clinical guidelines in this field.
This promotional round table meeting has been organised and fully funded by Bayer PLC and is intended for UK heath care professionals only. Prescribing and Adverse event reporting will be available at the meeting.
View Prescribing Information and Adverse Event Reporting for Xarelto® (rivaroxaban)
Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc. Tel: 01182 063500 Fax: 01182 063703 Email: pvuk@bayer.com. Further information is available on the "contact" tab at www.bayer.co.uk.
RP-XAR-GB-5380 May 2024
May 8, 2024 15:15
The PERIOD Study - learning on managing anticoagulation and menstruation
Jignesh Patel
Jignesh Patel is a clinical academic, specialising in anticoagulant drug therapy and is based between the Department of Haematological Medicine, King’s College Hospital and the Institute of Pharmaceutical Science, King’s College London.
Jig’s research is concerned with the optimal use of anticoagulant therapy in clinical practice and primarily focuses on addressing anticoagulant drug dosing issues where uncertainties exist. A particular focus of Jig's research is anticoagulation therapy as it relates to women’s health.
May 8, 2024 16:15
First Kind Sponsored Symposium
Dr Indira Natarajan
Since his appointment as Consultant Stroke Physician in 2008, Dr Indira Natarajan has held various leadership positions within stroke care, both regionally and nationally. Dr Indira has always been a champion and ambassador for stroke victims, with roles in Midlands Stroke Clinical Network and University Hospital of North Midlands NHS Trust. He has raised the profile of services in all aspects of care from Stroke prevention to end of life support for stroke patients in the community, and is widely known for all his innovative work.
Dr Indira has pioneered innovations in the area of interface, working for stroke prevention in patients with arterial fibrillation (AF) and the introduction of Sky Medical Technology’s geko device as an adjunct to current VTE prevention guidelines which has benefited a lot of stroke patients. Dr Indira has been played a key role in winning several awards for innovation in stroke practice, including Health and Social Awards for Stroke Services and the Health Care Pioneers award showcasing Best Practice in AF presented by the Atrial Fibrillation Academy.
Embracing innovation and update on a multi-centre randomised self-controlled trial (RCT) using the geko™ device for post stroke unmet need VTE prophylaxis